SABA Alone no Longer Recommended for Asthma Management

SABA Alone no Longer Recommended for Asthma Management

The Global Initiative for Asthma (GINA) critically revises evidence on asthma management yearly and provides a structured set of recommendations. The 2020 GINA Report maintains a major change in the management recommendations, which were introduced in 2019, in relation to pharmacological treatment. GINA no longer recommends treatment of asthma in adults and adolescents with short-acting beta-2 agonists alone.

Modern Medicine – Issue 5 2021